Research area: Infectious diseases

Description

The EPIVAC group was formed within the primary health services of Tarragona-Valls and comprises a multidisciplinary group of researchers and primary health care professionals. It is a wll consolidated group accredited by IDIAP Jordi Gol and by AGAUR (agency for the management of university and research grants of the Catalan Generalitat). Basically the group carries out population-based clinical an epidemiological research into infectious respiratory diseases which are preventable by vaccination.

Research Lines

Epidemiology of Community-Acquired Pneumonia (CAP) in the general population, Epidemiology of pneumococcal diseases in the general population, but especially among infants and old people, Evaluation of the effectiveness of the 23-valent pneumococcal polysaccharide vaccine in people over 50 and the heptavalent conjugate vaccine in infants, Evaluation of the effectiveness of the anti-flu vaccine in the general population and in specific high-risk subgroups.

Members

Projects

The group participates in the following projects:

PI: Vila Corcoles, Angel. Efectividad clínica de la vacunación antineumocócica conjugada versus polisacárida en adultos con distintas condiciones de riesgo: estudio de cohortes de base poblacional. Funding: Departament de Salut. Duration: 2017 - 2019

PI: Vila Corcoles, Angel. Efectividad clínica de la vacuna antineumocócica conjugada 13-valente versus vacuna polisacárida 23-valente en los adultos mayores de 50 años: estudio de cohortes de base poblacional. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2018

PI: Moragas Moreno, Ana. Anàlisi de l'evolució clínica i complicacions de la faringitis aguda en adults i adolescents i associació amb l'etiologia de la infecció. Funding: ICS - Institut Català de la Salut. Duration: 2015 - 2017

Publications

The group participates in the following publications:

Ochoa-Gondar O, Hospital I, Vila-Corcoles A, Aragon M, Jariod M, de Diego C, Satue E; EPIVAC Study Group. Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study. BMC public health. 2017 Jun; 17(1):610. doi:10.1186/s12889-017-4529-8. Epub 2017 Jun 29. pmc:PMC5492923. PMID:28662648. IF: 2,265.

Vila-Córcoles A, Ochoa-Gondar O, Satué E, de Diego C, Vila-Rovira M, Jariod M. Estimates of Target Population for Pneumococcal Vaccination in People over 50 years in Catalonia and Spain. Rev Esp Salud Publica. 2017 Mar 15;91. pii:e201703029. Spanish. PubMed PMID: 28300793. IF: 0,690.

Vila-Córcoles A, Ochoa-Gondar O. Pneumococcal disease in adults: Risk levels and vaccine recommendations. Atencion primaria. 2017 Feb; 49(2):111-117. doi:10.1016/j.aprim.2016.06.007. Epub 2016 Oct 17. Spanish. PMID:27765456. IF: 1,042.

Indicators